RT Journal Article
SR Electronic
T1 Quantifying the impact of US state non-pharmaceutical interventions on COVID-19 transmission
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.30.20142877
DO 10.1101/2020.06.30.20142877
A1 Korevaar, Hannah M.
A1 Becker, Alexander D.
A1 Miller, Ian F.
A1 Grenfell, Bryan T.
A1 Metcalf, C. Jessica E.
A1 Mina, Michael J.
YR 2020
UL http://medrxiv.org/content/early/2020/07/01/2020.06.30.20142877.abstract
AB COVID-19 is an ongoing public health emergency. Without a vaccine or effective antivirals, non-pharmaceutical interventions form the foundation of current response efforts. Quantifying the efficacy of these interventions is crucial. Using mortality data and a classification guide of state level responses, we relate the intensity of interventions to statistical estimates of transmission, finding that more stringent control measures are associated with larger reductions in disease proliferation. Additionally, we observe that transmission increases with population density, but not population size. These results may help inform future response efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementHMK funding: was supported by The Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number P2CHD047879. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. ADB and IFM were supported by National Science Foundation Graduate Research Fellowships.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe COVID-19 data used in this paper is publicly available. The code and csv files needed for analysis are linked in a github repository. https://github.com/hkorevaar/US_NPI_Re